1.22
+0.02(+1.67%)
Currency In USD
| Previous Close | 1.2 |
| Open | 1.17 |
| Day High | 1.23 |
| Day Low | 1.15 |
| 52-Week High | 2.41 |
| 52-Week Low | 0.92 |
| Volume | 271,481 |
| Average Volume | 1.75M |
| Market Cap | 463.38M |
| PE | -3.81 |
| EPS | -0.32 |
| Moving Average 50 Days | 1.11 |
| Moving Average 200 Days | 1.5 |
| Change | 0.02 |
If you invested $1000 in Standard BioTools Inc. (LAB) 10 years ago, it would be worth $52.07 as of July 01, 2025 at a share price of $1.22. Whereas If you bought $1000 worth of Standard BioTools Inc. (LAB) shares 5 years ago, it would be worth $281.11 as of July 01, 2025 at a share price of $1.22.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
GlobeNewswire Inc.
Jun 23, 2025 11:05 AM GMT
Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Str
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
GlobeNewswire Inc.
May 30, 2025 11:00 AM GMT
Featuring top researchers and industry experts using high-throughput proteomics to drive breakthroughs in population health, translational research and clinical developmentSOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTo
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
GlobeNewswire Inc.
Apr 24, 2025 11:00 AM GMT
Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer re